Anti-BCMA CAR T Cells


Anti-BCMA CAR T Cells are a BCMA targeted CAR T Cell therapy being developed at the National Cancer Institute.

SparkCures ID 127
Generic Name Anti-BCMA CAR T Cells
Treatment Classifications
Treatment Targets

Clinical Trials

All Clinical Trials

View all active clinical trials around the US.

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Smoldering Myeloma
Monoclonal Gammopathy of Undetermined Significance (MGUS)


There are no resources, links or videos to display for this treatment.